********* Breakfast Brief
Industry Expert Sees the Path Forward for Antisense
*********’s Tim McGowen spoke with Gil Price M.D. Antisense Therapeutics Limited’s US based Consultant Medical Director about his role with ANP. Dr Price shares his insights into the DMD treatment space and thoughts on ANP’s upcoming FDA interactions .
WATCH VIDEO
Very interesting...
https://www.*********.com.au/2021/03/17/industry-expert-sees-the-path-forward-for-antisense-therapeutics/
- Forums
- ASX - By Stock
- PER
- Sarepta gene therapy study missed key target in Duchennes
Sarepta gene therapy study missed key target in Duchennes, page-338
-
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.001(1.27%) |
Mkt cap ! $82.94M |
Open | High | Low | Value | Volume |
8.0¢ | 8.3¢ | 7.9¢ | $461.5K | 5.711M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 844186 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 292500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 844186 | 0.080 |
8 | 506274 | 0.079 |
5 | 575000 | 0.078 |
8 | 1027327 | 0.077 |
4 | 346421 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 292500 | 1 |
0.083 | 30000 | 1 |
0.084 | 93750 | 1 |
0.085 | 187500 | 2 |
0.086 | 250000 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online